Forums
New posts
New posts
Search forums
Market
Domains/Websites Wanted
.com Domain Market
gTLD Domain Market
ccTLD Domain Market
Web3 Domain Market
Third-Level Domain Market
Adult Domain Market
What's New
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Account Upgrade
Premium Members Directory
Log in
Register
What's New
calendar
Search
Search
Search titles only
By:
New posts
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Enjoy unlimited access to all forum features for FREE! Optional upgrade available for extra perks.
Forums
Other
The Watercooler
There I Was Just Reading The News Bulletins And ............. :o)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Bill Roy" data-source="post: 2221712" data-attributes="member: 68151"><p>Through the day I have been watching the 'news' slowly start to mount around the world about the endolysin breakthrough. It seems that from a small conference in London this week it is now being recognised as a major breakthrough worldwide in the fight against MRSA, etc., which of course is a very good thing for me ( <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="smilie smilie--sprite smilie--sprite7" alt=":p" title="Stick Out Tongue :p" loading="lazy" data-shortname=":p" /> ). For any who are interested just do a Google news search for 'endolysin'.</p><p> </p><p>I have expanded the initial two registrations by adding the following domains:</p><p> </p><p>EndolysinTreatment</p><p>EndolysinTreatments</p><p>EndolysinTherapy</p><p>EndolysinTherapies</p><p> </p><p>(all .com of course)</p><p> </p><p>However, with all such successes they bring along their own set of problems. As it is at the moment no one will be willing to pay what the domains are worth (according to me of course). Now that leaves me with the dilemma of whether to develop the domains or not. So now I am having to consider looking for a 'proven' developer in the field of medicine and/or science who can utilize the domains and build appropriate sites on them with appropriate monetization.</p><p> </p><p>The other option is leasing, which though on paper makes great commercial sense, I have yet to see any real successes with.</p><p> </p><p>Headaches - I think it is soon going to be time for an aspirin (and I like everybody else refer to it as aspirin and not '2-acetoxybenzoic acid' - LOL).</p><p> </p><p>.......................</p><p> </p><p>Surprisingly this post was not appended to my post of earlier today as I expected it to be.</p><p> </p><p><u>EDIT</u></p><p> </p><p>Just read the following report in 'Nature Biotechnology News':</p><p> </p><p>"<em>Actavis snapped up Chicago-based Durata Therapeutics to gain a next-generation antibiotic to treat skin infections. On October 6 Actavis agreed to pay $675 million in cash and up to $146.5 million in milestones if Durata's new drug Dalvance (dalbavancin) meets regulatory and sales goals</em>."</p><p> </p><p>Somehow I think Actavis will be reappraising its 'valuation' IMO. LOL</p><p> </p><p>But it does show just what the industry is worth. <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="smilie smilie--sprite smilie--sprite2" alt=";)" title="Wink ;)" loading="lazy" data-shortname=";)" /></p></blockquote><p></p>
[QUOTE="Bill Roy, post: 2221712, member: 68151"] Through the day I have been watching the 'news' slowly start to mount around the world about the endolysin breakthrough. It seems that from a small conference in London this week it is now being recognised as a major breakthrough worldwide in the fight against MRSA, etc., which of course is a very good thing for me ( :p ). For any who are interested just do a Google news search for 'endolysin'. I have expanded the initial two registrations by adding the following domains: EndolysinTreatment EndolysinTreatments EndolysinTherapy EndolysinTherapies (all .com of course) However, with all such successes they bring along their own set of problems. As it is at the moment no one will be willing to pay what the domains are worth (according to me of course). Now that leaves me with the dilemma of whether to develop the domains or not. So now I am having to consider looking for a 'proven' developer in the field of medicine and/or science who can utilize the domains and build appropriate sites on them with appropriate monetization. The other option is leasing, which though on paper makes great commercial sense, I have yet to see any real successes with. Headaches - I think it is soon going to be time for an aspirin (and I like everybody else refer to it as aspirin and not '2-acetoxybenzoic acid' - LOL). ....................... Surprisingly this post was not appended to my post of earlier today as I expected it to be. [U]EDIT[/U] Just read the following report in 'Nature Biotechnology News': "[I]Actavis snapped up Chicago-based Durata Therapeutics to gain a next-generation antibiotic to treat skin infections. On October 6 Actavis agreed to pay $675 million in cash and up to $146.5 million in milestones if Durata's new drug Dalvance (dalbavancin) meets regulatory and sales goals[/I]." Somehow I think Actavis will be reappraising its 'valuation' IMO. LOL But it does show just what the industry is worth. ;) [/QUOTE]
Insert quotes…
Verification
Post reply
Forums
Other
The Watercooler
There I Was Just Reading The News Bulletins And ............. :o)
Top
Bottom